Claude Runs Its Own Protein Design Campaigns, Beats the Drug Discovery Industry Norm
Today we're covering the biggest AI stories of August 20th, 2026. Anthropic published research showing its Mythos Preview and Opus 4.8 models ran protein design campaigns largely on their own, a key early step in drug discovery, hitting working molecules on 14 out of 15 targets with 22 to 35 percent success rates on molecules that actually gripped their target, well above the typical 10 to 15 percent industry norm, using just one expert written prompt plus internet access and tools, with outside labs Twist Bioscience and Adaptyv Bio handling the physical lab work and measurements. In a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.